Daxor (DXR) News Today → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free DXR Stock Alerts $9.65 0.00 (0.00%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsHeadlinesSEC FilingsStock AnalysisChartFinancialsHeadlinesSEC Filings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNew Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestionfinance.yahoo.com - April 16 at 8:30 AMDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)finance.yahoo.com - April 15 at 8:11 AMDaxor Corporation to Exhibit at the American College of Cardiology for ACC.24finance.yahoo.com - April 1 at 9:49 AMDaxor CFO Michel Robert J buys $6.5k in company stockinvesting.com - March 29 at 4:43 PMDestiny Tech100 Incmoney.usnews.com - March 28 at 4:41 PMDaxor Corporation (NASDAQ:DXR) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 28 at 11:41 AMDaxor Corp.wsj.com - March 23 at 5:37 PMDaxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024finance.yahoo.com - March 22 at 8:09 AMMulti-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patientsfinance.yahoo.com - March 8 at 9:13 AMDaxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitionsfinance.yahoo.com - February 12 at 8:10 AMDaxor Stock (NASDAQ:DXR) Insider Tradesbenzinga.com - February 9 at 8:42 PMDaxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accountsfinance.yahoo.com - February 7 at 12:43 PMDaxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual Meetingfinance.yahoo.com - January 29 at 8:38 AMDaxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congressfinance.yahoo.com - January 16 at 9:46 AMDAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMESfinance.yahoo.com - January 9 at 10:23 AMDaxor seeks US FDA approval for blood volume analysermsn.com - January 3 at 1:03 PMDaxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzerfinance.yahoo.com - January 2 at 9:07 AMAspira Women’s Health GAAP EPS of -$0.48 beats by $0.03, revenue of $2.22M misses by $0.68Mseekingalpha.com - November 13 at 6:17 PMDaxor Corporation: New Randomized Controlled Trial Demonstrates the Efficacy of Daxor's BVA Guided-Care in Heart Failure Patientsfinanznachrichten.de - November 13 at 1:16 PMNew Randomized Controlled Trial Demonstrates the Efficacy of Daxor’s BVA Guided-Care in Heart Failure Patientsfinance.yahoo.com - November 13 at 8:16 AMDaxor Corporation Awarded New Patent for Remote Monitoring of Blood Volumefinance.yahoo.com - November 9 at 8:56 AMNeuronetics GAAP EPS of -$0.33 misses by $0.02, revenue of $17.9M beats by $0.32Mmsn.com - November 7 at 9:31 AMChief Financial Officer at Daxor Acquires Company Stock Options Worth 5,000 Sharesbenzinga.com - November 5 at 6:52 PMExpert Panelists Advocate Use of Daxor’s Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific Meetingfinance.yahoo.com - October 13 at 8:59 AMNew Data from Banner University Medicine Demonstrating Effectiveness of BVA-100® Use in Ambulatory Heart Failure Patients Presented at Heart Failure Society of America Annual Scientific Meetingfinance.yahoo.com - October 11 at 9:09 AMDaxor Corporation Awarded Support from the National Institutes of Health (NIH) Catalyze Preclinical Services Programfinance.yahoo.com - October 4 at 8:10 AMDaxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2023finance.yahoo.com - September 27 at 9:04 AMDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE FALL’23 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100®)finance.yahoo.com - September 26 at 8:47 AMMaxim Group Keeps Their Buy Rating on Daxor (DXR)markets.businessinsider.com - September 13 at 2:29 PMDaxor Corporation Awarded $305K Grant from the National Institutes of Health to Develop Blood Volume Guidance Software in Sepsis Patientsfinance.yahoo.com - September 11 at 2:28 PMDaxor Corporation to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 7 at 9:54 AMDaxor's Diagnostics Test Kits Revenue Climbs in 1Hmarketwatch.com - August 28 at 5:28 PMJACC-HF Reports Successful Heart Failure Trial With Daxor BVA-100®finance.yahoo.com - August 10 at 9:17 AMJACC-HF Study Compares Daxor’s BVA-100® Volume Metric to CardioMEMS® Pressure Metric in Heart Failure Patientsfinance.yahoo.com - July 12 at 8:45 AMDaxor Corporation Announces Further Acquisitions and Increased Utilization of its BVA-100® Blood Volume Diagnostic Throughout the U.S.finance.yahoo.com - July 11 at 9:35 AMDaxor Corporation Awarded $1.1 Million Contract from the United States Defense Health Agency for Added Capabilities to its Point-of-Care Blood Volume Analyzerfinance.yahoo.com - July 5 at 9:50 AMDaxor Corporation Announces Partial Exercise of Over-Allotment Option in Secondary Offeringfinance.yahoo.com - June 22 at 7:38 PMDaxor Corporation to Showcase the Benefits of BVA-100® Guided Care at the American Association of Heart Failure Nurses (AAHFN) 19th Annual Meetingfinance.yahoo.com - June 20 at 10:41 AMDaxor Accelerates Blood Volume Analysis Adoption with the Launch of ezBVA Lab Servicesfinance.yahoo.com - June 15 at 8:38 AMDaxor Corporation to Participate in the Maxim Group Virtual Healthcare Conferencefinance.yahoo.com - June 12 at 4:27 PMDaxor Corporation Announces Closing of $4.0 Million Underwritten Public Offeringfinance.yahoo.com - May 25 at 3:44 PMWhy Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarketmsn.com - May 22 at 12:53 PMDaxor Nosedives on Stock Offeringmsn.com - May 22 at 12:37 PMDaxor shares tumble after pricing stock offering at discountseekingalpha.com - May 22 at 12:37 PMDaxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offeringfinance.yahoo.com - May 22 at 12:37 PMDaxor stock tumbles 22% premarket after announcing plans to issue stockmsn.com - May 22 at 7:37 AMDaxor Shares Tumble Premarket on Plans for Public Offering >DXRmarketwatch.com - May 22 at 7:37 AMDaxor Corporation Announces Proposed Underwritten Public Offeringfinance.yahoo.com - May 19 at 5:18 PMNew Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomesfinance.yahoo.com - May 18 at 9:12 AMNew Studies Presented at the 43rd International Society for Heart and Lung Transplant Validate the Applicability of the BVA-100® Blood Test for Patients with Advanced Heart Failurefinance.yahoo.com - April 20 at 10:21 AM Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address AI finds its first serious application (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry DXR Media Mentions By Week DXR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DXR News Sentiment▼0.000.34▲Average Medical News Sentiment DXR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DXR Articles This Week▼01▲DXR Articles Average Week Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Retractable Technologies News Today Ekso Bionics News Today Cidara Therapeutics News Today Jaguar Health News Today InspireMD News Today EUDA Health News Today United Health Products News Today Apyx Medical News Today Cytosorbents News Today Immuneering News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:DXR) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryHas Jeff Bezos Found the Next Nvidia?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
